TransMedics TMDX
$85.25 −$8.77 (-9.33%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $85.60 +0.41%
Open$90.81
Prev close$94.02
Day range$83.89 – $91.62
Volume1.59M
Market cap$2.96B
P/E (TTM)23.2
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$203.01M+41.1% YoY
Operating profit$28.14M+20.8% YoY
Net profit$17.07M-29.8% YoY
Diluted EPS$0.46-30.3% YoY
Free cash flow$27.60M-55.4% YoY
Operating cash flow$36.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin58.6%
Operating margin11.9%
Net margin19.9%
Return on equity31.9%
Return on assets11.7%
Return on invested capital13.9%
Current ratio4.53
Liabilities / assets63.7%
Cash & investments$492.96M
Total debt$863.26M
Net cash (debt)-$370.30M
Free cash flow / sales6.1%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $203.01M | $189.95M | $173.93M | $605.49M | $160.76M |
| Total Operating Revenue | $203.01M | $189.95M | $173.93M | $605.49M | $160.76M |
| Cost of Revenue | $84.35M | $76.75M | $72.77M | $242.69M | $67.35M |
| Gross Profit | $118.66M | $113.20M | $101.16M | $362.81M | $93.41M |
| Operating Expense | $90.52M | $89.46M | $87.86M | $254.22M | $72.14M |
| Selling and Admin Expenses | $56.77M | $53.54M | $56.92M | $185.17M | $55.96M |
| -Selling & Marketing Expense | $210,000.00 | $1.72M | $1.27M | $4.32M | $1.27M |
| -General & Admin Expense | $56.56M | $51.82M | $55.65M | $180.85M | $54.69M |
| Research & Development | $29.18M | $31.63M | $24.88M | $69.06M | $20.70M |
| Depreciation & Amortization & Depletion | $4.56M | $4.29M | $6.06M | – | – |
| -Depreciation & Amortization | $4.56M | $4.29M | $6.06M | – | – |
| Operating Profit | $28.14M | $23.74M | $13.30M | $108.58M | $21.27M |
| Net Non-Operating Interest Income (Expense) | -$7.27M | -$4.23M | -$7.17M | -$13.78M | -$3.35M |
| Non-Operating Interest Expense | $7.27M | $7.23M | $7.17M | $13.78M | $3.35M |
| Other Income (Expense) | $3.23M | -$100,000.00 | $2.36M | $12.72M | $3.71M |
| Other Non-Operating Income (Expenses) | $3.23M | – | $2.36M | $12.72M | $3.71M |
| Pretax Profit | $24.10M | $19.41M | $8.49M | $107.52M | $21.63M |
| Tax | $7.03M | $4.72M | $1.17M | -$82.77M | -$83.75M |
| Net Profit | $17.07M | $14.68M | $7.32M | $190.29M | $105.38M |
| Profit from Continuing Operations | $17.07M | $14.68M | $7.32M | $190.29M | $105.38M |
| Net Income to Parent Company | $17.07M | $14.68M | $7.32M | $190.29M | $105.38M |
| Net Income to Common Stockholders | $17.07M | $14.68M | $7.32M | $190.29M | $105.38M |
| Basic EPS | $0.49 | $0.42 | $0.21 | $5.60 | $3.08 |
| Diluted EPS | $0.46 | $0.41 | $0.20 | $4.87 | $2.62 |
| Non-Operating Interest Income | – | $3.00M | – | – | – |
| Gain on Sale of Security | – | -$100,000.00 | – | – | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.52B | $1.46B | $1.43B | $1.07B | $1.07B |
| Total Current Assets | $692.46M | $651.12M | $619.28M | $637.78M | $637.78M |
| Cash and Cash Equivalents & Short-Term Investments | $492.96M | $472.68M | $461.74M | $488.37M | $488.37M |
| -Cash and Cash Equivalents | $492.96M | $472.68M | $461.74M | $488.37M | $488.37M |
| Receivables | $114.94M | $104.14M | $90.73M | $84.28M | $84.28M |
| -Accounts Receivable | $114.94M | $104.14M | $90.73M | $84.28M | $84.28M |
| Inventory | $58.37M | $54.14M | $49.89M | $48.88M | $48.88M |
| Other Current Assets | $26.19M | $20.17M | $16.92M | $16.25M | $16.25M |
| Total Non-Current Assets | $825.48M | $813.27M | $815.54M | $430.59M | $430.59M |
| Net PPE | $711.23M | $702.42M | $700.97M | $332.81M | $332.81M |
| -Gross PPE | $801.82M | $784.38M | $774.80M | $398.88M | $398.88M |
| -Accumulated Depreciation | -$90.59M | -$81.96M | -$73.82M | -$66.07M | -$66.07M |
| Goodwill and Other Intangible Assets | $20.83M | $11.55M | $11.55M | $13.50M | $13.50M |
| -Goodwill | $18.02M | $11.55M | $11.55M | $11.55M | $11.55M |
| -Other Intangible Assets | $2.82M | – | – | $1.95M | $1.95M |
| Non-Current Deferred Assets | $72.79M | $78.68M | $82.48M | $83.54M | $83.54M |
| Other Non-Current Assets | $20.63M | $20.63M | $20.54M | $739,000.00 | $739,000.00 |
| Total Liabilities | $967.23M | $946.34M | $940.81M | $595.27M | $595.27M |
| Total Current Liabilities | $152.86M | $98.28M | $91.92M | $89.31M | $89.31M |
| Payables | $10.14M | $12.91M | $11.15M | $10.35M | $10.35M |
| -Accounts Payable | $10.14M | $12.91M | $11.15M | $10.35M | $10.35M |
| Current Accrued Expenses | $82.76M | $58.60M | $59.32M | $62.74M | $62.74M |
| Short-Term Debt and Capital Lease Obligation | $58.46M | $23.65M | $18.51M | $13.31M | $13.31M |
| -Current Debt | $54.82M | $20.00M | $15.00M | $10.00M | $10.00M |
| -Current Capital Lease Obligation | $3.64M | $3.65M | $3.51M | $3.31M | $3.31M |
| Current Deferred Liabilities | $1.50M | $3.13M | $2.95M | $2.91M | $2.91M |
| Total Non-Current Liabilities | $814.37M | $848.06M | $848.89M | $505.97M | $505.97M |
| Long Term Debt and Capital Lease Obligation | $808.44M | $844.07M | $844.91M | $505.97M | $505.97M |
| -Long Term Debt | $454.99M | $494.00M | $498.20M | $502.39M | $502.39M |
| -Long Term Capital Lease Obligation | $353.45M | $350.07M | $346.71M | $3.58M | $3.58M |
| Other Non-Current Liabilities | $5.93M | $3.99M | $3.99M | – | – |
| Total Equity | $550.71M | $518.05M | $494.01M | $473.10M | $473.10M |
| Stockholders' Equity | $550.71M | $518.05M | $494.01M | $473.10M | $473.10M |
| Capital Stock | $789.90M | $774.22M | $764.64M | $750.93M | $750.93M |
| -Common Stock | $789.90M | $774.22M | $764.64M | $750.93M | $750.93M |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Retained Earnings | -$238.88M | -$255.95M | -$270.64M | -$277.95M | -$277.95M |
| Gains/Losses Not Affecting Retained Earnings | -$306,000.00 | -$210,000.00 | $2,000.00 | $124,000.00 | $124,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $36.00M | $17.31M | $24.53M | $192.84M | $34.51M |
| Net cash flow from continuing operations | $36.00M | $17.31M | $24.53M | $192.84M | $34.51M |
| Net Income from Continuing Operations | $17.07M | $14.68M | $7.32M | $190.29M | $105.38M |
| Gain/Loss from Continuing Operations | $258,000.00 | $166,000.00 | $486,000.00 | -$1.54M | -$141,000.00 |
| Depreciation & Depletion & Amortization | $10.84M | $10.24M | $11.86M | $27.19M | $7.47M |
| Deferred Tax | $5.89M | $3.80M | $1.07M | -$83.54M | -$83.54M |
| Other Non-Cash Items | $5.40M | $5.26M | $5.20M | $5.21M | $1.29M |
| Change in Working Capital | -$16.05M | -$25.44M | -$11.35M | $18.38M | -$5.34M |
| -Change in Receivables | -$8.12M | -$13.43M | -$6.52M | $13.95M | -$3.58M |
| -Change in Inventory | -$9.11M | -$6.35M | -$3.90M | -$7.72M | -$6.53M |
| -Change in Prepaid Assets | -$4.56M | -$4.35M | $1.96M | -$3.76M | $1.06M |
| -Change in Payables and Accrued Expense | $8.25M | -$632,000.00 | -$1.98M | $17.68M | $4.90M |
| -Change in Other Current Assets | $9,000.00 | -$87,000.00 | -$155,000.00 | -$23,000.00 | -$13,000.00 |
| -Change in Other Current Liabilities | -$888,000.00 | -$783,000.00 | -$805,000.00 | -$2.90M | -$777,000.00 |
| -Change In Other Working Capital | -$1.63M | $185,000.00 | $40,000.00 | $1.14M | -$399,000.00 |
| Net cash flow from investing | -$13.71M | -$7.09M | -$36.66M | -$59.25M | -$15.51M |
| Net Cash Flow from Continuing Investing Activities | -$13.71M | -$7.09M | -$36.66M | -$59.25M | -$15.51M |
| Net PPE Purchase and Sale | -$8.40M | -$7.09M | -$36.66M | -$59.25M | -$15.51M |
| Financing Cash Flow | -$1.92M | $970,000.00 | $3.76M | $16.86M | $3.10M |
| Net Cash Flow from Continuing Financing Activities | -$1.92M | $970,000.00 | $3.76M | $16.86M | $3.10M |
| Proceeds from Stock Option Exercised | $3.23M | $1.01M | $3.90M | $17.00M | $3.10M |
| Net Other Financing Charges | -$140,000.00 | -$39,000.00 | -$138,000.00 | -$138,000.00 | $0.00 |
| Ending Cash Balance | $511.40M | $491.11M | $480.18M | $488.87M | $488.87M |
| Net Change in Cash | $20.38M | $11.19M | -$8.36M | $150.45M | $22.10M |
| Beginning Cash Balance | $491.11M | $480.18M | $488.87M | $337.15M | $466.67M |
| Effect of Exchange Rate Changes | -$92,000.00 | -$251,000.00 | -$327,000.00 | $1.27M | $94,000.00 |
| Free Cash Flow | $27.60M | $10.22M | -$12.12M | $133.59M | $19.00M |
| Net Intangibles Purchase and Sale | – | – | – | $0.00 | – |
| Net Business Purchase and Sale | – | – | – | $0.00 | $0.00 |
| Net Issuance Payments Of Debt | – | – | – | $0.00 | $0.00 |
No comments yet — be the first to weigh in on TMDX.
Sign in to join the discussion.